共 2 条
[2]
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies[J] . Thai M. Cao,Ruby M. Wong,Kevin Sheehan,Ginna G. Laport,Keith E. Stockerl-Goldstein,Laura J. Johnston,Judith A. Shizuru,Robert S. Negrin,Robert Lowsky. Experimental Hematology . 2005 (3)